{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:10:35Z","timestamp":1791508235303,"version":"4.3.4"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Prod. Bioprospect."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ulcerative colitis (UC) is a recurring autoimmune disorder characterized by persistent inflammation in the mucosal lining of the lower part of the large intestine. Conventional treatment options such as salicylates, corticosteroids, and immunosuppressants often come with severe side effects, limited bioavailability, and the development of drug resistance, which hampers their therapeutic effectiveness. Therefore, it is imperative to explore natural strategies as safe and alternative treatments for UC. Currently, around 40% of UC patients find relief through natural constituents, which can help reduce toxic side effects and maintain clinical remission. This review aims to provide a summary of both preclinical and clinical evidence supporting the efficacy of various natural substances in the prophylaxis of UC. These natural options include plant extracts, essential oils, nutraceuticals, and phytochemicals. Furthermore, we will delve into the potential mechanisms that underlie the protective and curative actions of these novel herbal agents. In summary, this review will explore the effectiveness of natural remedies for UC, shedding light on their preclinical and clinical findings and the mechanisms behind their therapeutic actions. These alternatives offer hope for improved treatment outcomes and reduced side effects for individuals suffering from this challenging autoimmune condition.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s13659-024-00463-x","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T05:11:03Z","timestamp":1722316263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Natural approaches for the management of ulcerative colitis: evidence of preclinical and clinical investigations"],"prefix":"10.1007","volume":"14","author":[{"given":"Rudra Narayan","family":"Subudhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Poonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"issue":"9","key":"463_CR1","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.cgh.2022.06.030","volume":"21","author":"MJ Buie","year":"2023","unstructured":"Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, Kotze PG, Gearry RB, Ng SC, Mak JW, Abreu MT. Global hospitalization trends for Crohn\u2019s disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses. Clin Gastroenterol Hepatol. 2023;21(9):2211\u201321. https:\/\/doi.org\/10.1016\/j.cgh.2022.06.030.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"463_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/17474124.2021.1840976","volume":"15","author":"SC Wei","year":"2021","unstructured":"Wei SC, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJ, Koram N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Rev Gastroenterol Hepatol. 2021;15(3):275\u201389. https:\/\/doi.org\/10.1080\/17474124.2021.1840976.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10","key":"463_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/ueg2.12350","volume":"10","author":"S Aniwan","year":"2022","unstructured":"Aniwan S, Santiago P, Loftus EV Jr, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United Eur Gastroenterol J. 2022;10(10):1063\u201376. https:\/\/doi.org\/10.1002\/ueg2.12350.","journal-title":"United Eur Gastroenterol J"},{"issue":"5","key":"463_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","volume":"165","author":"JD Lewis","year":"2023","unstructured":"Lewis JD, Parlett LE, Funk ML, Brensinger C, Pate V, Wu Q, Dawwas GK, Weiss A, Constant BD, McCauley M, Haynes K. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology. 2023;165(5):1197\u2013205. https:\/\/doi.org\/10.1053\/j.gastro.2023.07.003.","journal-title":"Gastroenterology"},{"key":"463_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154333","volume":"248","author":"F Weber","year":"2023","unstructured":"Weber F, Eger KI, March C, Croner RS, Meyer F. Manifestation of acute appendicitis as known but paradox visceral side effect of ulcerative colitis anti-inflammatory therapy with januskinase-inhibitor Tofacitinib (Xeljanz\u2122). Pathol Res Pract. 2023;248: 154333. https:\/\/doi.org\/10.1016\/j.prp.2023.154333.","journal-title":"Pathol Res Pract"},{"issue":"10","key":"463_CR6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330(10):951\u201365. https:\/\/doi.org\/10.1001\/jama.2023.15389.","journal-title":"JAMA"},{"key":"463_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.12.029","author":"WJ Sandborn","year":"2023","unstructured":"Sandborn WJ, Danese S, Leszczyszyn J, Romatowski J, Altintas E, Peeva E, Hassan-Zahraee M, Vincent MS, Reddy PS, Banfield C, Salganik M. Oral ritlecitinib and brepocitinib for moderate-to-severe ulcerative colitis: results from a randomized, phase 2b study. Clin Gastroenterol Hepatol. 2023. https:\/\/doi.org\/10.1016\/j.cgh.2022.12.029.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"463_CR8","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1007\/s10620-023-08095-w","volume":"68","author":"J Lim","year":"2023","unstructured":"Lim J, Rezaie A. Irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease: a practical approach to diagnosis and treatment of organic causes. Dig Dis Sci. 2023;68(11):4081\u201397. https:\/\/doi.org\/10.1007\/s10620-023-08095-w.","journal-title":"Dig Dis Sci"},{"key":"463_CR9","doi-asserted-by":"publisher","unstructured":"Singh S, Dulai PS. Ulcerative colitis: clinical manifestations and management. Yamada's Textbook of Gastroenterology. 2022:1248\u201393.https:\/\/doi.org\/10.1002\/9781118512104.ch28","DOI":"10.1002\/9781118512104.ch28"},{"key":"463_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00001-2","author":"PG Kotze","year":"2022","unstructured":"Kotze PG, Heuthorst L, Lightner AL, Dami\u00e3o AO, Bemelman WA. New insights on the surgical management of ulcerative colitis in the 21st century. Lancet Gastroenterol Hepatol. 2022. https:\/\/doi.org\/10.1016\/S2468-1253(22)00001-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"463_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro M, Czuber-Dochan W, Eder P. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis. 2022;16(1):2\u201317. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab178.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"463_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1751-2980.12849","volume":"21","author":"XY Guo","year":"2020","unstructured":"Guo XY, Liu XJ, Hao JY. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment. J Dig Dis. 2020;21(3):147\u201359. https:\/\/doi.org\/10.1111\/1751-2980.12849.","journal-title":"J Dig Dis"},{"issue":"1","key":"463_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.dld.2020.10.018","volume":"53","author":"A Amiot","year":"2021","unstructured":"Amiot A, Bouguen G, Bonnaud G, Bouhnik Y, Hagege H, Peyrin-Biroulet L, Abitbol V, Malamut G, Amiot A, Boruchowicz A, Siproudhis L. Clinical guidelines for the management of inflammatory bowel disease: update of a French national consensus. Dig Liver Dis. 2021;53(1):35\u201343. https:\/\/doi.org\/10.1016\/j.dld.2020.10.018.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"463_CR14","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00423-021-02295-6","volume":"406","author":"S Liu","year":"2021","unstructured":"Liu S, Eisenstein S. State-of-the-art surgery for ulcerative colitis. Langenbeck\u2019s Arch Surg. 2021;406(6):1751\u201361. https:\/\/doi.org\/10.1007\/s00423-021-02295-6.","journal-title":"Langenbeck's Arch Surg"},{"key":"463_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.964793","volume":"13","author":"L Lu","year":"2022","unstructured":"Lu L, Dong J, Liu Y, Qian Y, Zhang G, Zhou W, Zhao A, Ji G, Xu H. New insights into natural products that target the gut microbiota: effects on the prevention and treatment of colorectal cancer. Front Pharmacol. 2022;13: 964793. https:\/\/doi.org\/10.3389\/fphar.2022.964793.","journal-title":"Front Pharmacol"},{"key":"463_CR16","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2014.12.2.103","author":"CC Salibay","year":"2021","unstructured":"Salibay CC, Mahboob T, Verma AK, San Sebastian JS, Tabo HA, Raju CS, Nissapatorn V. Natural product\u2013derived drugs for the treatment of inflammatory bowel diseases (IBD). Inflamm Nat Prod. 2021. https:\/\/doi.org\/10.5217\/ir.2014.12.2.103.","journal-title":"Inflamm Nat Prod"},{"key":"463_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114086","volume":"158","author":"JC Xue","year":"2023","unstructured":"Xue JC, Yuan S, Meng H, Hou XT, Li J, Zhang HM, Chen LL, Zhang CH, Zhang QG. The role and mechanism of flavonoid herbal natural products in ulcerative colitis. Biomed Pharmacother. 2023;158: 114086. https:\/\/doi.org\/10.1016\/j.biopha.2022.114086.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"463_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.684486","volume":"14","author":"L Duan","year":"2021","unstructured":"Duan L, Cheng S, Li L, Liu Y, Wang D, Liu G. Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease. Front Pharmacol. 2021;14(12): 684486. https:\/\/doi.org\/10.3389\/fphar.2021.684486.","journal-title":"Front Pharmacol"},{"key":"463_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111628","volume":"144","author":"EK Akkol","year":"2020","unstructured":"Akkol EK, Karpuz B, Sobarzo-S\u00e1nchez E, Khan H. A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitis. Food Chem Toxicol. 2020;144: 111628. https:\/\/doi.org\/10.1016\/j.fct.2020.111628.","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"463_CR20","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1007\/s10620-023-08122-w","volume":"68","author":"KA Dunleavy","year":"2023","unstructured":"Dunleavy KA, Raffals LE, Camilleri M. Intestinal barrier dysfunction in inflammatory bowel disease: underpinning pathogenesis and therapeutics. Digest Dis Sci. 2023;68(12):4306\u201320. https:\/\/doi.org\/10.1007\/s10620-023-08122-w.","journal-title":"Digest Dis Sci."},{"key":"463_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109466","volume":"113","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zhang Y, Jin T, Yi C, Ocansey DK, Mao F. The role of NOD2 in intestinal immune response and microbiota modulation: a therapeutic target in inflammatory bowel disease. Int Immunopharmacol. 2022;113: 109466. https:\/\/doi.org\/10.1016\/j.intimp.2022.109466.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"463_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ame2.12262","volume":"5","author":"Q Fu","year":"2022","unstructured":"Fu Q, Song T, Ma X, Cui J. Research progress on the relationship between intestinal microecology and intestinal bowel disease. Anim Models Exp Med. 2022;5(4):297\u2013310. https:\/\/doi.org\/10.1002\/ame2.12262.","journal-title":"Anim Models Exp Med."},{"key":"463_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114985","volume":"164","author":"J Chu","year":"2023","unstructured":"Chu J, Feng S, Guo C, Xue B, He K, Li L. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: s review. Biomed Pharmacother. 2023;164: 114985. https:\/\/doi.org\/10.1016\/j.biopha.2023.114985.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"463_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/cells10010111","volume":"10","author":"M Mahapatro","year":"2021","unstructured":"Mahapatro M, Erkert L, Becker C. Cytokine-mediated crosstalk between immune cells and epithelial cells in the gut. Cells. 2021;10(1):111. https:\/\/doi.org\/10.3390\/cells10010111.","journal-title":"Cells"},{"issue":"3","key":"463_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.103017","volume":"21","author":"H Nakase","year":"2022","unstructured":"Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmunity Rev. 2022;21(3): 103017. https:\/\/doi.org\/10.1016\/j.autrev.2021.103017.","journal-title":"Autoimmunity Rev"},{"issue":"4","key":"463_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","volume":"49","author":"L Du","year":"2020","unstructured":"Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin. 2020;49(4):643\u201354. https:\/\/doi.org\/10.1016\/j.gtc.2020.07.005.","journal-title":"Gastroenterol Clin"},{"key":"463_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-020-00246-4","volume":"17","author":"A Kaur","year":"2020","unstructured":"Kaur A, Goggolidou P. Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies. J Inflamm. 2020;17:1\u20138. https:\/\/doi.org\/10.1186\/s12950-020-00246-4.","journal-title":"J Inflamm"},{"issue":"2","key":"463_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/jcm11020400","volume":"11","author":"A Ka\u0142u\u017cna","year":"2022","unstructured":"Ka\u0142u\u017cna A, Olczyk P, Komosi\u0144ska-Vassev K. The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis. J Clin Med. 2022;11(2):400. https:\/\/doi.org\/10.3390\/jcm11020400.","journal-title":"J Clin Med"},{"issue":"3","key":"463_CR29","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/ijms24032696","volume":"24","author":"R Gomez-Bris","year":"2023","unstructured":"Gomez-Bris R, Saez A, Herrero-Fernandez B, Rius C, Sanchez-Martinez H, Gonzalez-Granado JM. CD4 T-cell subsets and the pathophysiology of inflammatory bowel disease. Int J Mol Sci. 2023;24(3):2696. https:\/\/doi.org\/10.3390\/ijms24032696.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"463_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/cells9010110","volume":"9","author":"I Tindemans","year":"2020","unstructured":"Tindemans I, Joosse ME, Samsom JN. Dissecting the heterogeneity in T-cell mediated inflammation in IBD. Cells. 2020;9(1):110. https:\/\/doi.org\/10.3390\/cells9010110.","journal-title":"Cells"},{"key":"463_CR31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2147\/JIR.S353038","volume":"15","author":"Q Lu","year":"2022","unstructured":"Lu Q, Yang MF, Liang YJ, Xu J, Xu HM, Nie YQ, Wang LS, Yao J, Li DF. Immunology of inflammatory bowel disease: molecular mechanisms and therapeutics. J Inflamm Res. 2022;15:1825\u201344. https:\/\/doi.org\/10.2147\/JIR.S353038.","journal-title":"J Inflamm Res"},{"key":"463_CR32","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00011-020-01398-y","volume":"69","author":"TC Moreira Lopes","year":"2020","unstructured":"Moreira Lopes TC, Mosser DM, Gon\u00e7alves R. Macrophage polarization in intestinal inflammation and gut homeostasis. Inflamm Res. 2020;69:1163\u201372. https:\/\/doi.org\/10.1007\/s00011-020-01398-y.","journal-title":"Inflamm Res"},{"issue":"5","key":"463_CR33","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.jcmgh.2021.08.021","volume":"12","author":"JL Yip","year":"2021","unstructured":"Yip JL, Balasuriya GK, Spencer SJ, Hill-Yardin EL. The role of intestinal macrophages in gastrointestinal homeostasis: heterogeneity and implications in disease. Cell Mol Gastroenterol Hepatol. 2021;12(5):1701\u201318. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.08.021.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"463_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104364","volume":"365","author":"C Xiang","year":"2021","unstructured":"Xiang C, Liu M, Lu Q, Fan C, Lu H, Feng C, Yang X, Li H, Tang W. Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis. Cell Immunol. 2021;365: 104364. https:\/\/doi.org\/10.1016\/j.cellimm.2021.104364.","journal-title":"Cell Immunol"},{"issue":"10","key":"463_CR35","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/ibd\/izab029","volume":"27","author":"S Dharmasiri","year":"2021","unstructured":"Dharmasiri S, Garrido-Martin EM, Harris RJ, Bateman AC, Collins JE, Cummings JF, Sanchez-Elsner T. Human intestinal macrophages are involved in the pathology of both ulcerative colitis and Crohn disease. Inflamm Bowel Dis. 2021;27(10):1641\u201352. https:\/\/doi.org\/10.1093\/ibd\/izab029.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"463_CR36","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.pec.2021.10.017","volume":"105","author":"S Gohil","year":"2022","unstructured":"Gohil S, Majd Z, Sheneman JC, Abughosh SM. Interventions to improve medication adherence in inflammatory bowel disease: a systematic review. Patient Educ Counsel. 2022;105(7):1731\u201342. https:\/\/doi.org\/10.1016\/j.pec.2021.10.017.","journal-title":"Patient Educ Counsel."},{"issue":"12","key":"463_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2019.02.004","volume":"65","author":"M Gajendran","year":"2019","unstructured":"Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65(12): 100851. https:\/\/doi.org\/10.1016\/j.disamonth.2019.02.004.","journal-title":"Dis Mon"},{"issue":"4","key":"463_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ecco-jcc\/jjz163","volume":"14","author":"RL Smith","year":"2020","unstructured":"Smith RL, Taylor KM, Friedman AB, Gibson RN, Gibson PR. Systematic review: clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis. J Crohns Colitis. 2020;14(4):465\u201379. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz163.","journal-title":"J Crohns Colitis"},{"issue":"33\u201334","key":"463_CR39","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3238\/arztebl.2020.0564","volume":"117","author":"T Kucharzik","year":"2020","unstructured":"Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative colitis\u2014diagnostic and therapeutic algorithms. Dtsch Arztebl Int. 2020;117(33\u201334):564. https:\/\/doi.org\/10.3238\/arztebl.2020.0564.","journal-title":"Dtsch Arztebl Int"},{"issue":"7","key":"463_CR40","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cgh.2018.09.034","volume":"17","author":"JE Axelrad","year":"2019","unstructured":"Axelrad JE, Ol\u00e9n O, Askling J, Lebwohl B, Khalili H, Sachs MC, Ludvigsson JF. Gastrointestinal infection increases odds of inflammatory bowel disease in a nationwide case\u2013control study. Clin Gastroenterol Hepatol. 2019;17(7):1311\u201322. https:\/\/doi.org\/10.1016\/j.cgh.2018.09.034.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"463_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/ijms21010243","volume":"21","author":"AN Frickenstein","year":"2019","unstructured":"Frickenstein AN, Jones MA, Behkam B, McNally LR. Imaging inflammation and infection in the gastrointestinal tract. Int J Mol Sci. 2019;21(1):243. https:\/\/doi.org\/10.3390\/ijms21010243.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"463_CR42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S2468-1253(21)00372-1","volume":"7","author":"K Takenaka","year":"2022","unstructured":"Takenaka K, Fujii T, Kawamoto A, Suzuki K, Shimizu H, Maeyashiki C, Yamaji O, Motobayashi M, Igarashi A, Hanazawa R, Hibiya S. Deep neural network for video colonoscopy of ulcerative colitis: a cross-sectional study. Lancet Gastroenterol Hepatol. 2022;7(3):230\u20137. https:\/\/doi.org\/10.1016\/S2468-1253(21)00372-1.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"463_CR43","doi-asserted-by":"publisher","unstructured":"Mokter MF, Oh J, Tavanapong W, Wong J, de Groen PC. Classification of ulcerative colitis severity in colonoscopy videos using vascular pattern detection. InMachine Learning in Medical Imaging: 11th International Workshop, MLMI 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, 2020, Proceedings 11 2020 (pp. 552\u2013562). Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-59861-7_56","DOI":"10.1007\/978-3-030-59861-7_56"},{"issue":"1","key":"463_CR44","doi-asserted-by":"publisher","first-page":"18243","DOI":"10.1038\/s41598-021-97366-5","volume":"11","author":"B Linggi","year":"2021","unstructured":"Linggi B, Jairath V, Zou G, Shackelton LM, McGovern DP, Salas A, Verstockt B, Silverberg MS, Nayeri S, Feagan BG, van de Casteele N. Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis. Sci Rep. 2021;11(1):18243. https:\/\/doi.org\/10.1038\/s41598-021-97366-5.","journal-title":"Sci Rep"},{"issue":"10","key":"463_CR45","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1111\/apt.16083","volume":"52","author":"R Battat","year":"2020","unstructured":"Battat R, Vande Casteele N, Pai RK, Wang Z, Zou G, McDonald JW, Duijvestein M, Jeyarajah J, Parker CE, Van Viegen T, Nelson SA. Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Aliment Pharmacol Ther. 2020;52(10):1574\u201382. https:\/\/doi.org\/10.1111\/apt.16083.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"463_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-022-02178-0","volume":"22","author":"SB Park","year":"2022","unstructured":"Park SB, Kim SJ, Lee J, Lee YJ, Baek DH, Seo GS, Kim ES, Kim SW, Kim SY. Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis. BMC Gastroenterol. 2022;22(1):1\u20137. https:\/\/doi.org\/10.1186\/s12876-022-02178-0.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"463_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.lers.2021.04.003","volume":"4","author":"H Chen","year":"2021","unstructured":"Chen H, Wu L, Wang M, Shao B, Ye L, Zhang Y, Cao Q. Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis. Laparosc Endosc Robot Surg. 2021;4(2):33\u20139. https:\/\/doi.org\/10.1016\/j.lers.2021.04.003.","journal-title":"Laparosc Endosc Robot Surg"},{"issue":"2","key":"463_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/gastroent12020019","volume":"12","author":"C Pagnini","year":"2021","unstructured":"Pagnini C, Di Paolo MC, Mariani BM, Urgesi R, Pallotta L, Vitale MA, Villotti G, d\u2019Alba L, De Cesare MA, Di Giulio E, Graziani MG. Mayo endoscopic score and ulcerative colitis endoscopic index are equally effective for endoscopic activity evaluation in ulcerative colitis patients in a real-life setting. Gastroenterol Insights. 2021;12(2):217\u201324. https:\/\/doi.org\/10.3390\/gastroent12020019.","journal-title":"Gastroenterol Insights"},{"issue":"10","key":"463_CR49","doi-asserted-by":"publisher","first-page":"14365","DOI":"10.1111\/ijcp.14365","volume":"75","author":"BH Xiao","year":"2021","unstructured":"Xiao BH, Ma XD, Lv JJ, Yang T, Liu XJ, An LY, Qi YX, Lu ML, Duan YQ, Sun DL. Systematic evaluation of the diagnostic approach of inflammatory bowel disease guidelines. Int J Clin Pract. 2021;75(10):14365. https:\/\/doi.org\/10.1111\/ijcp.14365.","journal-title":"Int J Clin Pract"},{"key":"463_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2022-102117","author":"N Shaban","year":"2022","unstructured":"Shaban N, Hoad CL, Naim I, Alshammari M, Radford SJ, Clarke C, Marciani L, Moran G. Imaging in inflammatory bowel disease: current and future perspectives. Frontline Gastroenterol. 2022. https:\/\/doi.org\/10.1136\/flgastro-2022-102117.","journal-title":"Frontline Gastroenterol."},{"issue":"1","key":"463_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cgh.2019.07.005","volume":"18","author":"C Le Berre","year":"2020","unstructured":"Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L. Ulcerative colitis and Crohn\u2019s disease have similar burden and goals for treatment. Clin Gastroenterol Hepatol. 2020;18(1):14\u201323. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.005.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"463_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2023.2292768","volume":"13","author":"F D\u2019Amico","year":"2023","unstructured":"D\u2019Amico F, Fasulo E, Jairath V, Paridaens K, Peyrin-Biroulet L, Danese S. Management and treatment optimization of patients with mild to moderate ulcerative colitis. Expert Rev Clin Immunol. 2023;13:1\u20134. https:\/\/doi.org\/10.1080\/1744666X.2023.2292768.","journal-title":"Expert Rev Clin Immunol"},{"key":"463_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765474","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med. 2021;8: 765474. https:\/\/doi.org\/10.3389\/fmed.2021.765474.","journal-title":"Front Med"},{"issue":"1","key":"463_CR54","doi-asserted-by":"publisher","first-page":"2219427","DOI":"10.1080\/10717544.2023.2219427","volume":"30","author":"M Chen","year":"2023","unstructured":"Chen M, Lan H, Jin K, Chen Y. Responsive nanosystems for targeted therapy of ulcerative colitis: current practices and future perspectives. Drug Deliv. 2023;30(1):2219427. https:\/\/doi.org\/10.1080\/10717544.2023.2219427.","journal-title":"Drug Deliv"},{"issue":"9","key":"463_CR55","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3390\/jcm11092302","volume":"11","author":"F Ferretti","year":"2022","unstructured":"Ferretti F, Cannatelli R, Monico MC, Maconi G, Ardizzone S. An update on current pharmacotherapeutic options for the treatment of ulcerative colitis. J Clin Med. 2022;11(9):2302. https:\/\/doi.org\/10.3390\/jcm11092302.","journal-title":"J Clin Med"},{"issue":"7","key":"463_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S2468-1253(21)00065-0","volume":"6","author":"D Alsoud","year":"2021","unstructured":"Alsoud D, Verstockt B, Fiocchi C, Vermeire S. Breaking the therapeutic ceiling in drug development in ulcerative colitis. Lancet Gastroenterol Hepatol. 2021;6(7):589\u201395. https:\/\/doi.org\/10.1016\/S2468-1253(21)00065-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"463_CR57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10787-022-00931-1","volume":"30","author":"M Gupta","year":"2022","unstructured":"Gupta M, Mishra V, Gulati M, Kapoor B, Kaur A, Gupta R, Tambuwala MM. Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacology. 2022;30(2):397\u2013434. https:\/\/doi.org\/10.1007\/s10787-022-00931-1.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"463_CR58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ijms24010095","volume":"24","author":"KD Moudgil","year":"2022","unstructured":"Moudgil KD, Venkatesha SH. The anti-inflammatory and immunomodulatory activities of natural products to control autoimmune inflammation. Int J Mol Sci. 2022;24(1):95. https:\/\/doi.org\/10.3390\/ijms24010095.","journal-title":"Int J Mol Sci"},{"issue":"151","key":"463_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113158","volume":"1","author":"N El Menyiy","year":"2022","unstructured":"El Menyiy N, El Allam A, Aboulaghras S, Jaouadi I, Bakrim S, El Omari N, Shariati MA, Miftakhutdinov A, Wilairatana P, Mubarak MS, Bouyahya A. Inflammatory auto-immune diseases of the intestine and their management by natural bioactive compounds. Biomed Pharmacother. 2022;1(151): 113158. https:\/\/doi.org\/10.1016\/j.biopha.2022.113158.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"463_CR60","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1586\/17474124.2016.1145546","volume":"13","author":"MM Davila","year":"2023","unstructured":"Davila MM, Papada E. The role of plant-derived natural products in the management of inflammatory bowel disease\u2014what is the clinical evidence so far? Life. 2023;13(8):1703. https:\/\/doi.org\/10.1586\/17474124.2016.1145546.","journal-title":"Life"},{"issue":"10","key":"463_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1045","volume":"11","author":"N Guo","year":"2023","unstructured":"Guo N, Lv LL. Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis. Immunity, Inflamm Dis. 2023;11(10): e1045. https:\/\/doi.org\/10.1002\/iid3.1045.","journal-title":"Immunity, Inflamm Dis"},{"issue":"141","key":"463_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111931","volume":"1","author":"Y Chang","year":"2021","unstructured":"Chang Y, Zhai L, Peng J, Wu H, Bian Z, Xiao H. Phytochemicals as regulators of Th17\/Treg balance in inflammatory bowel diseases. Biomed Pharmacother. 2021;1(141): 111931. https:\/\/doi.org\/10.1016\/j.biopha.2021.111931.","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"463_CR63","doi-asserted-by":"publisher","first-page":"1055914","DOI":"10.3389\/fimmu.2022.1055914","volume":"9","author":"L Chen","year":"2023","unstructured":"Chen L, Ruan G, Cheng Y, Yi A, Chen D, Wei Y. The role of Th17 cells in inflammatory bowel disease and the research progress. Front Immunol. 2023;9(13):1055914. https:\/\/doi.org\/10.3389\/fimmu.2022.1055914.","journal-title":"Front Immunol"},{"key":"463_CR64","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1155\/2021\/8816041","volume":"22","author":"J Zhao","year":"2021","unstructured":"Zhao J, Lu Q, Liu Y, Shi Z, Hu L, Zeng Z, Tu Y, Xiao Z, Xu Q. Th17 cells in inflammatory bowel disease: cytokines, plasticity, and therapies. J Immunol Res. 2021;22:2021. https:\/\/doi.org\/10.1155\/2021\/8816041.","journal-title":"J Immunol Res"},{"issue":"3","key":"463_CR65","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/ijms22030985","volume":"22","author":"G Caioni","year":"2021","unstructured":"Caioni G, Viscido A, Angelo M, Panella G, Castelli V, Merola C, Frieri G, Latella G, Cimini A, Benedetti E. Inflammatory bowel disease: new insights into the interplay between environmental factors and PPAR\u03b3. Int J Mol Sci. 2021;22(3):985. https:\/\/doi.org\/10.3390\/ijms22030985.","journal-title":"Int J Mol Sci."},{"issue":"221","key":"463_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113535","volume":"5","author":"C Villarroel-Vicente","year":"2021","unstructured":"Villarroel-Vicente C, Gutierrez-Palomo S, Ferri J, Cortes D, Cabedo N. Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: an overview. Eur J Med Chem. 2021;5(221): 113535. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113535.","journal-title":"Eur J Med Chem"},{"issue":"7","key":"463_CR67","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/ptr.6625","volume":"34","author":"B Venkataraman","year":"2020","unstructured":"Venkataraman B, Ojha S, Belur PD, Bhongade B, Raj V, Collin PD, Adrian TE, Subramanya SB. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor \u03b3 in inflammatory bowel diseases. Phytother Res. 2020;34(7):1530\u201349. https:\/\/doi.org\/10.1002\/ptr.6625.","journal-title":"Phytother Res"},{"issue":"2","key":"463_CR68","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/metabo13020243","volume":"13","author":"LF Laurindo","year":"2023","unstructured":"Laurindo LF, de Maio MC, Minniti G, de G\u00f3es CN, Barbalho SM, Quesada K, Guiguer EL, Sloan KP, Detregiachi CR, Ara\u00fajo AC, de Alvares GR. Effects of medicinal plants and phytochemicals in Nrf2 pathways during inflammatory bowel diseases and related colorectal cancer: a comprehensive review. Metabolites. 2023;13(2):243. https:\/\/doi.org\/10.3390\/metabo13020243.","journal-title":"Metabolites"},{"issue":"21","key":"463_CR69","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.1177\/17562848221138160","volume":"22","author":"H Liu","year":"2021","unstructured":"Liu H, Johnston LJ, Wang F, Ma X. Triggers for the nrf2\/are signaling pathway and its nutritional regulation: Potential therapeutic applications of ulcerative colitis. Int J Mol Sci. 2021;22(21):11411. https:\/\/doi.org\/10.1177\/17562848221138160.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"463_CR70","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/metabo13010096","volume":"13","author":"LF Laurindo","year":"2023","unstructured":"Laurindo LF, Santos AR, Carvalho AC, Bechara MD, Guiguer EL, Goulart RD, Vargas Sinatora R, Ara\u00fajo AC, Barbalho SM. Phytochemicals and regulation of NF-kB in inflammatory bowel diseases: an overview of in vitro and in vivo effects. Metabolites. 2023;13(1):96. https:\/\/doi.org\/10.3390\/metabo13010096.","journal-title":"Metabolites"},{"issue":"13","key":"463_CR71","doi-asserted-by":"publisher","first-page":"6939","DOI":"10.3390\/ijms23136939","volume":"23","author":"C Yu","year":"2022","unstructured":"Yu C, Wang D, Yang Z, Wang T. Pharmacological effects of polyphenol phytochemicals on the intestinal inflammation via targeting TLR4\/NF-\u03baB signaling pathway. Int J Mol Sci. 2022;23(13):6939. https:\/\/doi.org\/10.3390\/ijms23136939.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"463_CR72","doi-asserted-by":"publisher","first-page":"1155077","DOI":"10.3389\/fimmu.2023.1155077","volume":"1","author":"K Wang","year":"2023","unstructured":"Wang K, Mao T, Lu X, Wang M, Yun Y, Jia Z, Shi L, Jiang H, Li J, Shi R. A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals. Front Immunol. 2023;1(14):1155077. https:\/\/doi.org\/10.3389\/fimmu.2023.1155077.","journal-title":"Front Immunol"},{"issue":"3","key":"463_CR73","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/14728222.2021.1901079","volume":"25","author":"Y Du","year":"2021","unstructured":"Du Y, Rong L, Cong Y, Shen L, Zhang N, Wang B. Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease. Expert Opin Ther Targets. 2021;25(3):191\u2013209. https:\/\/doi.org\/10.1080\/14728222.2021.1901079.","journal-title":"Expert Opin Ther Targets"},{"key":"463_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118129","volume":"258","author":"RD do Nascimento","year":"2020","unstructured":"do Nascimento RD, da FonsecaMachado AP, Galvez J, Cazarin CB, Junior MR. Ulcerative colitis: gut microbiota, immunopathogenesis and application of natural products in animal models. Life Sci. 2020;258: 118129. https:\/\/doi.org\/10.1016\/j.lfs.2020.118129.","journal-title":"Life Sci"},{"issue":"3","key":"463_CR75","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5650\/jossess17184","volume":"67","author":"H Abe","year":"2018","unstructured":"Abe H, Ishioka M, Fujita Y, Umeno A, Yasunaga M, Sato A, Ohnishi S, Suzuki S, Ishida N, Shichiri M, Yoshida Y. Yuzu (Citrus junos Tanaka) peel attenuates dextran sulfate sodium-induced murine experimental colitis. J Oleo Sci. 2018;67(3):335\u201344. https:\/\/doi.org\/10.5650\/jossess17184.","journal-title":"J Oleo Sci"},{"issue":"18","key":"463_CR76","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.3390\/ijms21186963","volume":"21","author":"J Shin","year":"2020","unstructured":"Shin J, Song HY, Lee M. Sudachinoid-and ichangensin-type limonoids from Citrus junos downregulate pro-inflammatory cytokines. Int J Mol Sci. 2020;21(18):6963. https:\/\/doi.org\/10.3390\/ijms21186963.","journal-title":"Int J Mol Sci"},{"key":"463_CR77","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jff.2014.03.024","volume":"8","author":"SH Kim","year":"2014","unstructured":"Kim SH, Shin EJ, Hur HJ, Park JH, Sung MJ, Kwon DY, Hwang JT. Citrus junos Tanaka peel extract attenuates experimental colitis and inhibits tumour growth in a mouse xenograft model. J Funct Foods. 2014;8:301\u20138. https:\/\/doi.org\/10.1016\/j.jff.2014.03.024.","journal-title":"J Funct Foods."},{"issue":"9","key":"463_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184709","volume":"12","author":"Y Kim","year":"2017","unstructured":"Kim Y, Wu AG, Jaja-Chimedza A, Graf BL, Waterman C, Verzi MP, Raskin I. Isothiocyanate-enriched moringa seed extract alleviates ulcerative colitis symptoms in mice. PLoS ONE. 2017;12(9): e0184709. https:\/\/doi.org\/10.1371\/journal.pone.0184709.","journal-title":"PLoS ONE"},{"issue":"9","key":"463_CR79","doi-asserted-by":"publisher","first-page":"1055791","DOI":"10.3389\/fnut.2022.1055791","volume":"10","author":"H Mohamed Husien","year":"2022","unstructured":"Mohamed Husien H, Peng W, Su H, Zhou R, Tao Y, Huang J, Liu M, Bo R, Li J. Moringa oleifera leaf polysaccharide alleviates experimental colitis by inhibiting inflammation and maintaining intestinal barrier. Front Nutr. 2022;10(9):1055791. https:\/\/doi.org\/10.3389\/fnut.2022.1055791.","journal-title":"Front Nutr"},{"key":"463_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.924178","volume":"13","author":"ZS Hong","year":"2022","unstructured":"Hong ZS, Xie J, Wang XF, Dai JJ, Mao JY, Bai YY, Sheng J, Tian Y. Moringa oleifera Lam. peptide remodels intestinal mucosal barrier by inhibiting JAK-STAT activation and modulating gut microbiota in colitis. Front Immunol. 2022;13: 924178. https:\/\/doi.org\/10.3389\/fimmu.2022.924178.","journal-title":"Front Immunol"},{"key":"463_CR81","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6295402","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Peng L, Li W, Dai T, Nie L, Xie J, Ai Y, Li L, Tian Y, Sheng J. Polyphenol extract of Moringa oleifera leaves alleviates colonic inflammation in dextran sulfate sodium-treated mice. Evid Based Complement Altern Med. 2020. https:\/\/doi.org\/10.1155\/2020\/6295402.","journal-title":"Evid Based Complement Altern Med."},{"issue":"71","key":"463_CR82","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.intimp.2019.02.038","volume":"1","author":"S Shao","year":"2019","unstructured":"Shao S, Wang D, Zheng W, Li X, Zhang H, Zhao D, Wang M. A unique polysaccharide from Hericium erinaceus mycelium ameliorates acetic acid-induced ulcerative colitis rats by modulating the composition of the gut microbiota, short chain fatty acids levels and GPR41\/43 respectors. Int Immunopharmacol. 2019;1(71):411\u201322. https:\/\/doi.org\/10.1016\/j.intimp.2019.02.038.","journal-title":"Int Immunopharmacol"},{"key":"463_CR83","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijbiomac.2018.12.092","volume":"125","author":"D Wang","year":"2019","unstructured":"Wang D, Zhang Y, Yang S, Zhao D, Wang M. A polysaccharide from cultured mycelium of Hericium erinaceus relieves ulcerative colitis by counteracting oxidative stress and improving mitochondrial function. Int J Biol Macromol. 2019;125:572\u20139. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.12.092.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"463_CR84","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/nu15030739","volume":"15","author":"Y Ren","year":"2023","unstructured":"Ren Y, Sun Q, Gao R, Sheng Y, Guan T, Li W, Zhou L, Liu C, Li H, Lu Z, Yu L. Low weight polysaccharide of Hericium erinaceus ameliorates colitis via inhibiting the NLRP3 inflammasome activation in association with gut microbiota modulation. Nutrients. 2023;15(3):739. https:\/\/doi.org\/10.3390\/nu15030739.","journal-title":"Nutrients"},{"issue":"Suppl 1","key":"463_CR85","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.3904\/kjim.2019.050","volume":"36","author":"A Durmus","year":"2021","unstructured":"Durmus A, Durmus I, Bender O, Karatepe O. The effect of Hericium erinaceum on the prevention of chemically induced experimental colitis in rats. Korean J Intern Med. 2021;36(Suppl 1):S44. https:\/\/doi.org\/10.3904\/kjim.2019.050.","journal-title":"Korean J Intern Med"},{"key":"463_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1215329","author":"AG Gravina","year":"2023","unstructured":"Gravina AG, Pellegrino R, Palladino G, Coppola A, Brandimarte G, Tuccillo C, Ciardiello F, Romano M, Federico A. Hericium erinaceus, in combination with natural flavonoid\/alkaloid and B3\/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1215329.","journal-title":"Front Immunol"},{"key":"463_CR87","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-016-2750-x","volume":"419","author":"TA Shah","year":"2016","unstructured":"Shah TA, Parikh M, Patel KV, Patel KG, Joshi CG, Gandhi TR. Evaluation of the effect of Punica granatum juice and punicalagin on NF\u03baB modulation in inflammatory bowel disease. Mol Cell Biochem. 2016;419:65\u201374. https:\/\/doi.org\/10.1007\/s11010-016-2750-x.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"463_CR88","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ctcp.2015.03.001","volume":"21","author":"M Kamali","year":"2015","unstructured":"Kamali M, Tavakoli H, Khodadoost M, Daghaghzadeh H, Kamalinejad M, Gachkar L, Mansourian M, Adibi P. Efficacy of the Punica granatum peels aqueous extract for symptom management in ulcerative colitis patients. A randomized, placebo-controlled, clinical trial. Complement Ther Clin Pract. 2015;21(3):141\u20136. https:\/\/doi.org\/10.1016\/j.ctcp.2015.03.001.","journal-title":"Complement Ther Clin Pract"},{"key":"463_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114385","volume":"279","author":"M Kalyankumarraju","year":"2021","unstructured":"Kalyankumarraju M, Puppala ER, Ahmed S, Kumar GJ, Tene K, Syamprasad NP, Sahu BD, Barua CC, Naidu VG. Zanthoxylum alatum Roxb. seed extract ameliorates stress aggravated DSS-induced ulcerative colitis in mice: plausible role on NF-\u03baB signaling axis. J Ethnopharmacol. 2021;279: 114385. https:\/\/doi.org\/10.1016\/j.jep.2021.114385.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"463_CR90","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3329\/bjp.v13i3.35648","volume":"13","author":"B Zaware","year":"2018","unstructured":"Zaware B, Gilhotra R, Chaudhari SR. Potential of Mimosa pudica leaf in the treatment of ulcerative colitis in rat. Bangladesh J Pharmacol. 2018;13(3):241\u20137. https:\/\/doi.org\/10.3329\/bjp.v13i3.35648.","journal-title":"Bangladesh J Pharmacol."},{"issue":"22","key":"463_CR91","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.3390\/foods11223559","volume":"11","author":"L Recinella","year":"2022","unstructured":"Recinella L, Gorica E, Chiavaroli A, Fraschetti C, Filippi A, Cesa S, Cairone F, Martelli A, Calderone V, Veschi S, Lanuti P. Anti-inflammatory and antioxidant effects induced by Allium sativum L. extracts on an ex vivo experimental model of ulcerative colitis. Foods. 2022;11(22):3559. https:\/\/doi.org\/10.3390\/foods11223559.","journal-title":"Foods"},{"key":"463_CR92","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1155\/2020\/8785497","volume":"6","author":"G Owusu","year":"2020","unstructured":"Owusu G, Obiri DD, Ainooson GK, Osafo N, Antwi AO, Duduyemi BM, Ansah C. Acetic acid-induced ulcerative colitis in Sprague Dawley rats is suppressed by hydroethanolic extract of Cordia vignei leaves through reduced serum levels of TNF-\u03b1 and IL-6. Int J Chronic Dis. 2020;6:2020. https:\/\/doi.org\/10.1155\/2020\/8785497.","journal-title":"Int J Chronic Dis"},{"key":"463_CR93","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4918453","author":"CF Adjouzem","year":"2020","unstructured":"Adjouzem CF, Gilbert A, Mbiantcha M, Yousseu Nana W, Matah Marthe Mba V, Djuichou Nguemnang SF, Tsafack EG, Atsamo AD. Effects of aqueous and methanolic extracts of stem bark of Ansonia bonnie De wild (A polynucleate) on dextran sodium sulfate-induced ulcerative colitis in Wistar rats. Evid Based Complement Altern Med. 2020. https:\/\/doi.org\/10.1155\/2020\/4918453.","journal-title":"Evid Based Complement Altern Med."},{"key":"463_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10314","author":"W Qin","year":"2022","unstructured":"Qin W, Luo H, Yang L, Hu D, Jiang SP, Peng DY, Hu JM, Liu SJ. Rubia cordifolia L. ameliorates DSS-induced ulcerative colitis in mice through dual inhibition of NLRP3 inflammasome and IL-6\/JAK2\/STAT3 pathways. Heliyon. 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10314.","journal-title":"Heliyon."},{"issue":"219","key":"463_CR95","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jep.2018.02.043","volume":"12","author":"RA Gupta","year":"2018","unstructured":"Gupta RA, Motiwala MN, Mahajan UN, Sabre SG. Protective effect of Sesbania grandiflora on acetic acid induced ulcerative colitis in mice by inhibition of TNF-\u03b1 and IL-6. J Ethnopharmacol. 2018;12(219):222\u201332. https:\/\/doi.org\/10.1016\/j.jep.2018.02.043.","journal-title":"J Ethnopharmacol"},{"key":"463_CR96","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nutres.2019.03.005","volume":"66","author":"MC Meurer","year":"2019","unstructured":"Meurer MC, Mees M, Mariano LN, Boeing T, Somensi LB, Mariott M, Dos Santos AC, Longo B, Fran\u00e7a TC, Klein-J\u00fanior LC, de Souza P. Hydroalcoholic extract of Tagetes erecta L. flowers, rich in the carotenoid lutein, attenuates inflammatory cytokine secretion and improves the oxidative stress in an animal model of ulcerative colitis. Nutr Res. 2019;66:95\u2013106. https:\/\/doi.org\/10.1016\/j.nutres.2019.03.005.","journal-title":"Nutr Res"},{"issue":"115","key":"463_CR97","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.fct.2018.03.002","volume":"1","author":"RS Almeer","year":"2018","unstructured":"Almeer RS, Mahmoud SM, Amin HK, Moneim AE. Ziziphus spina-christi fruit extract suppresses oxidative stress and p38 MAPK expression in ulcerative colitis in rats via induction of Nrf2 and HO-1 expression. Food Chem Toxicol. 2018;1(115):49\u201362. https:\/\/doi.org\/10.1016\/j.fct.2018.03.002.","journal-title":"Food Chem Toxicol"},{"key":"463_CR98","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.biopha.2017.05.057","volume":"91","author":"JK Suluvoy","year":"2017","unstructured":"Suluvoy JK, Sakthivel KM, Guruvayoorappan C, Grace VB. Protective effect of Averrhoa bilimbi L. fruit extract on ulcerative colitis in wistar rats via regulation of inflammatory mediators and cytokines. Biomed Pharmacother. 2017;91:1113\u201321. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.057.","journal-title":"Biomed Pharmacother"},{"issue":"166","key":"463_CR99","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jep.2015.03.027","volume":"26","author":"G Chen","year":"2015","unstructured":"Chen G, Yang Y, Liu M, Teng Z, Ye J, Xu Y, Cai X, Cheng X, Yang J, Hu C, Wang M. Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice. J Ethnopharmacol. 2015;26(166):149\u201356. https:\/\/doi.org\/10.1016\/j.jep.2015.03.027.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"463_CR100","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/molecules28041526","volume":"28","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang C, Wu J, Tan L, Gao P, Wu S, Tang D, Wang Q, Wang C, Li P, Liu J. Study on the comprehensive phytochemicals and the anti-ulcerative colitis effect of Saussurea pulchella. Molecules. 2023;28(4):1526. https:\/\/doi.org\/10.3390\/molecules28041526.","journal-title":"Molecules"},{"issue":"12","key":"463_CR101","doi-asserted-by":"publisher","first-page":"1291230","DOI":"10.3389\/fchem.2024.1291230","volume":"27","author":"IU Rehman","year":"2024","unstructured":"Rehman IU, Saleem M, Raza SA, Bashir S, Muhammad T, Asghar S, Qamar MU, Shah TA, Bin Jardan YA, Mekonnen AB, Bourhia M. Anti-ulcerative colitis effects of chemically characterized extracts from Calliandra haematocephala in acetic acid-induced ulcerative colitis. Front Chem. 2024;27(12):1291230. https:\/\/doi.org\/10.3389\/fchem.2024.1291230.","journal-title":"Front Chem"},{"issue":"12","key":"463_CR102","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3389\/fchem.2024.1291230","volume":"38","author":"K Devi","year":"2024","unstructured":"Devi K, Bali A, Bhatia P, Singh N, Jaggi AS. Exploring the ameliorative potential of Bacopa monnieri in acetic acid induced ulcerative colitis in mice. Nat Prod Res. 2024;38(12):2105\u201310. https:\/\/doi.org\/10.3389\/fchem.2024.1291230.","journal-title":"Nat Prod Res"},{"issue":"4","key":"463_CR103","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/md22040175","volume":"22","author":"W Jia","year":"2024","unstructured":"Jia W, Yu S, Liu X, Le Q, He X, Yu L, He J, Yang L, Gao H. Ethanol extract of limonium bicolor improves dextran sulfate sodium-induced ulcerative colitis by alleviating inflammation and restoring gut microbiota dysbiosis in mice. Mar Drugs. 2024;22(4):175. https:\/\/doi.org\/10.3390\/md22040175.","journal-title":"Mar Drugs"},{"key":"463_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2024.105672","volume":"16","author":"NA Abdellatif","year":"2024","unstructured":"Abdellatif NA, Eltamany EE, El-Shenawy NS, Nafie MS, Hassan YM, Al-Eisa RA, Badr JM, Abdelhameed RF. Cassia fistula leaves extract profiling and its emphasis on induced ulcerative colitis in male rats through inhibition of caspase 3 and cyclooxygenase-2. Arab J Chem. 2024;16: 105672. https:\/\/doi.org\/10.1016\/j.arabjc.2024.105672.","journal-title":"Arab J Chem"},{"issue":"301","key":"463_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115829","volume":"30","author":"Q Zhao","year":"2023","unstructured":"Zhao Q, Zhu L, Wang S, Gao Y, Jin F. Molecular mechanism of the anti-inflammatory effects of plant essential oils: a systematic review. J Ethnopharmacol. 2023;30(301): 115829. https:\/\/doi.org\/10.1016\/j.jep.2022.115829.","journal-title":"J Ethnopharmacol"},{"key":"463_CR106","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.2147\/JIR.S461466","volume":"17","author":"J Li","year":"2024","unstructured":"Li J, Zhang X, Luan F, Duan J, Zou J, Sun J, Shi Y, Guo D, Wang C, Wang X. Therapeutic potential of essential oils against ulcerative colitis: a review. J Inflamm Res. 2024;17:3527. https:\/\/doi.org\/10.2147\/JIR.S461466.","journal-title":"J Inflamm Res"},{"issue":"96","key":"463_CR107","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.biopha.2017.10.017","volume":"1","author":"MT de Santana Souza","year":"2017","unstructured":"de Santana Souza MT, Teixeira DF, de Oliveira JP, Oliveira AS, Quintans-Junior LJ, Correa CB, Camargo EA. Protective effect of carvacrol on acetic acid-induced colitis. Biomed Pharmacother. 2017;1(96):313\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.017.","journal-title":"Biomed Pharmacother"},{"key":"463_CR108","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X221130147","author":"M Liu","year":"2022","unstructured":"Liu M, Mao G, Zhou X, Wan X, Zhang F, Dai L, Chen Y, Dai N, Zhang Y, Du Q. Carvacrol ameliorates DSS-induced intestinal inflammation in rats by suppressing the TLR4\/NF-\u03baB pathway. Nat Prod Commun. 2022. https:\/\/doi.org\/10.1177\/1934578X221130147.","journal-title":"Nat Prod Commun"},{"issue":"24\u201326","key":"463_CR109","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.lfs.2013.04.013","volume":"92","author":"PA d\u2019Alessio","year":"2013","unstructured":"d\u2019Alessio PA, Ostan R, Bisson JF, Schulzke JD, Ursini MV, B\u00e9n\u00e9 MC. Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans. Life Sci. 2013;92(24\u201326):1151\u20136. https:\/\/doi.org\/10.1016\/j.lfs.2013.04.013.","journal-title":"Life Sci"},{"issue":"4","key":"463_CR110","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3892\/mmr.2017.6241","volume":"15","author":"L Yu","year":"2017","unstructured":"Yu L, Yan J, Sun Z. D-limonene exhibits anti-inflammatory and antioxidant properties in an ulcerative colitis rat model via regulation of iNOS, COX-2, PGE2 and ERK signaling pathways. Mol Med Rep. 2017;15(4):2339\u201346. https:\/\/doi.org\/10.3892\/mmr.2017.6241.","journal-title":"Mol Med Rep"},{"issue":"280","key":"463_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114462","volume":"15","author":"GR Estrella","year":"2021","unstructured":"Estrella GR, Eva GT, Alberto HL, Guadalupe VD, Azucena CV, Sandra OS, No\u00e9 AV, Javier LM. Limonene from Agastache mexicana essential oil produces antinociceptive effects, gastrointestinal protection and improves experimental ulcerative colitis. J Ethnopharmacol. 2021;15(280): 114462. https:\/\/doi.org\/10.1016\/j.jep.2021.114462.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"463_CR112","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.4314\/tjpr.v17i9.18","volume":"17","author":"DM Liu","year":"2018","unstructured":"Liu DM, Zhou CY, Meng XL, Wang P, Li W. Thymol exerts anti-inflammatory effect in dextran sulfate sodium-induced experimental murine colitis. Trop J Pharm Res. 2018;17(9):1803\u201310. https:\/\/doi.org\/10.4314\/tjpr.v17i9.18.","journal-title":"Trop J Pharm Res"},{"key":"463_CR113","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10787-019-00583-8","volume":"27","author":"M Chamanara","year":"2019","unstructured":"Chamanara M, Abdollahi A, Rezayat SM, Ghazi-Khansari M, Dehpour A, Nassireslami E, Rashidian A. Thymol reduces acetic acid-induced inflammatory response through inhibition of NF-kB signaling pathway in rat colon tissue. Inflammopharmacology. 2019;27:1275\u201383. https:\/\/doi.org\/10.1007\/s10787-019-00583-8.","journal-title":"Inflammopharmacology"},{"issue":"6","key":"463_CR114","doi-asserted-by":"publisher","first-page":"538","DOI":"10.22038\/AJP.2019.13383","volume":"9","author":"P Tahmasebi","year":"2019","unstructured":"Tahmasebi P, Froushani SM, Ahangaran NA. Thymol has beneficial effects on the experimental model of ulcerative colitis. Avicenna J Phytomed. 2019;9(6):538. https:\/\/doi.org\/10.22038\/AJP.2019.13383.","journal-title":"Avicenna J Phytomed."},{"issue":"805","key":"463_CR115","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejphar.2017.03.003","volume":"15","author":"M Ghasemi-Pirbaluti","year":"2017","unstructured":"Ghasemi-Pirbaluti M, Motaghi E, Bozorgi H. The effect of menthol on acute experimental colitis in rats. Eur J Pharmacol. 2017;15(805):101\u20137. https:\/\/doi.org\/10.1016\/j.ejphar.2017.03.003.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"463_CR116","first-page":"4210","volume":"10","author":"SM Bastaki","year":"2018","unstructured":"Bastaki SM, Adeghate E, Amir N, Ojha S, Oz M. Menthol inhibits oxidative stress and inflammation in acetic acid-induced colitis in rat colonic mucosa. Am J Transl Res. 2018;10(12):4210.","journal-title":"Am J Transl Res."},{"issue":"1","key":"463_CR117","first-page":"38","volume":"13","author":"L Luo","year":"2021","unstructured":"Luo L, Yan J, Chen B, Luo Y, Liu L, Sun Z, Lu Y. The effect of menthol supplement diet on colitis-induced colon tumorigenesis and intestinal microbiota. Am J Transl Res. 2021;13(1):38.","journal-title":"Am J Transl Res."},{"issue":"9","key":"463_CR118","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jpha.2023.07.001","volume":"13","author":"S Ma","year":"2023","unstructured":"Ma S, Yang B, Du Y, Lv Y, Liu J, Shi Y, Huang T, Xu H, Deng L, Chen X. 1, 8-cineole ameliorates colon injury by downregulating macrophage M1 polarization via inhibiting the HSP90-NLRP3-SGT1 complex. J Pharm Anal. 2023;13(9):984\u201398. https:\/\/doi.org\/10.1016\/j.jpha.2023.07.001.","journal-title":"J Pharm Anal."},{"issue":"7","key":"463_CR119","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.3390\/ijms24076160","volume":"24","author":"B Venkataraman","year":"2023","unstructured":"Venkataraman B, Almarzooqi S, Raj V, Bhongade BA, Patil RB, Subramanian VS, Attoub S, Rizvi TA, Adrian TE, Subramanya SB. Molecular docking identifies 1, 8-Cineole (Eucalyptol) as a novel PPAR\u03b3 agonist that alleviates colon inflammation. Int J Mol Sci. 2023;24(7):6160. https:\/\/doi.org\/10.3390\/ijms24076160.","journal-title":"Int J Mol Sci"},{"key":"463_CR120","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2022.36.S1.R3110","author":"SB Subramanya","year":"2022","unstructured":"Subramanya SB, Venkataraman B, Almarzooqi S, Raj V, Subramanian VS, Bhongade BA. 1, 8-Cineole, a bioactive monoterpenoid, mitigates colon inflammation by stimulating colon PPAR-\u03b3 transcription factor. FASEB J. 2022. https:\/\/doi.org\/10.1096\/fasebj.2022.36.S1.R3110.","journal-title":"FASEB J"},{"issue":"8","key":"463_CR121","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/10408398.2019.1570913","volume":"60","author":"I Hossen","year":"2022","unstructured":"Hossen I, Hua W, Ting L, Mehmood A, Jingyi S, Duoxia X, Yanping C, Hongqing W, Zhipeng G, Kaiqi Z, Fang Y. Phytochemicals and inflammatory bowel disease: a review. Crit Rev Food Sci Nutr. 2022;60(8):1321\u201345. https:\/\/doi.org\/10.1080\/10408398.2019.1570913.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"9","key":"463_CR122","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.3390\/molecules26092824","volume":"26","author":"SY Moon","year":"2021","unstructured":"Moon SY, Kim KD, Yoo J, Lee JH, Hwangbo C. Phytochemicals targeting JAK\u2013STAT pathways in inflammatory bowel disease: insights from animal models. Molecules. 2021;26(9):2824. https:\/\/doi.org\/10.3390\/molecules26092824.","journal-title":"Molecules"},{"key":"463_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1197144","author":"J Zhang","year":"2023","unstructured":"Zhang J, Sun S, Chen H, Feng Y, Li Y, Dong Z. Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1197144.","journal-title":"Front Pharmacol"},{"issue":"1","key":"463_CR124","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/08923973.2022.2112218","volume":"45","author":"H Zhang","year":"2023","unstructured":"Zhang H, Lang W, Li S, Xu C, Wang X, Li Y, Zhang Z, Wu T, Feng M. Corynoline ameliorates dextran sulfate sodium-induced colitis in mice by modulating Nrf2\/NF-\u03baB pathway. Immunopharmacol Immunotoxicol. 2023;45(1):26\u201334. https:\/\/doi.org\/10.1080\/08923973.2022.2112218.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"122","key":"463_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155153","volume":"1","author":"M Zhao","year":"2024","unstructured":"Zhao M, Li P, Qiao D, Hua S, Yue Q, Dai Y, Huang Y, Jiang J, Yin H, Li M, Ding Y. N6-methyladenosine modification of TSC1 mRNA contributes to macrophage polarization regulated by Coptisine in DSS-induced ulcerative colitis. Phytomedicine. 2024;1(122): 155153. https:\/\/doi.org\/10.1016\/j.phymed.2023.155153.","journal-title":"Phytomedicine"},{"issue":"3","key":"463_CR126","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/molecules28031060","volume":"28","author":"MN Zhang","year":"2023","unstructured":"Zhang MN, Xie R, Wang HG, Wen X, Wang JY, He L, Zhang MH, Yang XZ. Cepharanthine alleviates DSS-induced ulcerative colitis via regulating aconitate decarboxylase 1 expression and macrophage infiltration. Molecules. 2023;28(3):1060. https:\/\/doi.org\/10.3390\/molecules28031060.","journal-title":"Molecules"},{"issue":"13","key":"463_CR127","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.3390\/molecules28135277","volume":"28","author":"M Yue","year":"2023","unstructured":"Yue M, Huang J, Ma X, Huang P, Liu Y, Zeng J. Protopine alleviates dextran sodium sulfate-induced ulcerative colitis by improving intestinal barrier function and regulating intestinal microbiota. Molecules. 2023;28(13):5277. https:\/\/doi.org\/10.3390\/molecules28135277.","journal-title":"Molecules"},{"issue":"182","key":"463_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106244","volume":"1","author":"C Liu","year":"2023","unstructured":"Liu C, Wang R, Jiao X, Zhang J, Zhang C, Wang Z. Oxysophocarpine suppresses TRAF6 level to ameliorate oxidative stress and inflammatory factors secretion in mice with dextran sulphate sodium (DSS) induced-ulcerative colitis. Microb Pathog. 2023;1(182): 106244. https:\/\/doi.org\/10.1016\/j.micpath.2023.106244.","journal-title":"Microb Pathog"},{"issue":"120","key":"463_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110309","volume":"1","author":"M Ekhtiar","year":"2023","unstructured":"Ekhtiar M, Ghasemi-Dehnoo M, Mirzaei Y, Azadegan-Dehkordi F, Amini-Khoei H, Lorigooini Z, Samiei-Sefat A, Bagheri N. The coumaric acid and syringic acid ameliorate acetic acid-induced ulcerative colitis in rats via modulator of Nrf2\/HO-1 and pro-inflammatory cytokines. Int Immunopharmacol. 2023;1(120): 110309. https:\/\/doi.org\/10.1016\/j.intimp.2023.110309.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"463_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaim.2022.100544","volume":"14","author":"T Prakash","year":"2023","unstructured":"Prakash T, Janadri S. Anti-inflammatory effect of wedelolactone on DSS induced colitis in rats: IL-6\/STAT3 signaling pathway. J Ayurveda Integr Med. 2023;14(2): 100544. https:\/\/doi.org\/10.1016\/j.jaim.2022.100544.","journal-title":"J Ayurveda Integr Med."},{"key":"463_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1279029","author":"Y Zou","year":"2023","unstructured":"Zou Y, Ding W, Wu Y, Chen T, Ruan Z. Puerarin alleviates inflammation and pathological damage in colitis mice by regulating metabolism and gut microbiota. Front Microbiol. 2023. https:\/\/doi.org\/10.3389\/fmicb.2023.1279029.","journal-title":"Front Microbiol"},{"issue":"11","key":"463_CR132","doi-asserted-by":"publisher","first-page":"2200755","DOI":"10.1002\/mnfr.202200755","volume":"67","author":"L Yang","year":"2023","unstructured":"Yang L, Ma XY, Mu KX, Dai Y, Xia YF, Wei ZF. Galangin targets HSP90\u03b2 to alleviate ulcerative colitis by controlling fatty acid synthesis and subsequent NLRP3 inflammasome activation. Mol Nutr Food Res. 2023;67(11):2200755. https:\/\/doi.org\/10.1002\/mnfr.202200755.","journal-title":"Mol Nutr Food Res"},{"issue":"954","key":"463_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1279029","volume":"5","author":"X Shen","year":"2023","unstructured":"Shen X, Chen H, Wen T, Liu L, Yang Y, Xie F, Wang L. A natural chalcone cardamonin inhibits necroptosis and ameliorates dextran sulfate sodium (DSS)-induced colitis by targeting RIPK1\/3 kinases. Eur J Pharmacol. 2023;5(954): 175840. https:\/\/doi.org\/10.3389\/fmicb.2023.1279029.","journal-title":"Eur J Pharmacol"},{"key":"463_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-023-04746-8","volume":"21","author":"TS Alharbi","year":"2023","unstructured":"Alharbi TS, Alshammari ZS, Alanzi ZN, Althobaiti F, Elewa MA, Hashem KS, Al-Gayyar MM. Therapeutic effects of genistein in experimentally induced ulcerative colitis in rats via affecting mitochondrial biogenesis. Mol Cell Biochem. 2023;21:1\u20134. https:\/\/doi.org\/10.1007\/s11010-023-04746-8.","journal-title":"Mol Cell Biochem"},{"issue":"216","key":"463_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107687","volume":"1","author":"X Cao","year":"2020","unstructured":"Cao X, Cao L, Zhang W, Lu R, Bian JS, Nie X. Therapeutic potential of sulfur-containing natural products in inflammatory diseases. Pharmacol Ther. 2020;1(216): 107687. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107687.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"463_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.08.010","volume":"45","author":"KM Shirazi","year":"2021","unstructured":"Shirazi KM, Sotoudeh S, Shirazi AM, Moaddab SY, Nourpanah Z, Nikniaz Z. Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: a randomized, double-blind controlled clinical trial. Clin Res Hepatol Gastroenterol. 2021;45(4): 101532. https:\/\/doi.org\/10.1016\/j.clinre.2020.08.010.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"463_CR137","doi-asserted-by":"publisher","first-page":"2200784","DOI":"10.1002\/mnfr.202200784","volume":"20","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Guo Y, Zhang Q, Zhu Y, Xia Y, Wei Z, Dai Y. Diallyl trisulfide, a major bioactive constituent of garlic, promotes colonic mucosal healing in ulcerative colitis through accelerating focal adhesion assembly and consequent epithelial cell migration via the Rab21-Integrin \u03b21-Fak pathway. Mol Nutr Food Res. 2023;20:2200784. https:\/\/doi.org\/10.1002\/mnfr.202200784.","journal-title":"Mol Nutr Food Res"},{"issue":"216","key":"463_CR138","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22902","volume":"15","author":"A Lohning","year":"2021","unstructured":"Lohning A, Kidachi Y, Kamiie K, Sasaki K, Ryoyama K, Yamaguchi H. 6- (methylsulfinyl) hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3\u03b2). Eur J Med Chem. 2021;15(216): 113250. https:\/\/doi.org\/10.18632\/oncotarget.22902.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"463_CR139","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13568-020-01053-z","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Tan L, Li C, Wu H, Ran D, Zhang Z. Sulforaphane alter the microbiota and mitigate colitis severity on mice ulcerative colitis induced by DSS. AMB Express. 2020;10(1):119. https:\/\/doi.org\/10.1186\/s13568-020-01053-z.","journal-title":"AMB Express"},{"issue":"1","key":"463_CR140","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/1750-3841.15982","volume":"87","author":"L Pang","year":"2022","unstructured":"Pang L, Wang T, Liao Q, Cheng Y, Wang D, Li J, Fu C, Zhang C, Zhang J. Protective role of ergothioneine isolated from Pleurotus ostreatus against dextran sulfate sodium-induced ulcerative colitis in rat model. J Food Sci. 2022;87(1):415\u201326. https:\/\/doi.org\/10.1111\/1750-3841.15982.","journal-title":"J Food Sci"},{"issue":"24","key":"463_CR141","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.2174\/0929867329666211227121321","volume":"29","author":"AC Maio","year":"2022","unstructured":"Maio AC, Basile G, Iacopetta D, Catalano A, Ceramella J, Cafaro D, Saturnino C, Sinicropi MS. The significant role of nutraceutical compounds in ulcerative colitis treatment. Curr Med Chem. 2022;29(24):4216\u201334. https:\/\/doi.org\/10.2174\/0929867329666211227121321.","journal-title":"Curr Med Chem"},{"issue":"4","key":"463_CR142","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/0884533615586598","volume":"30","author":"AM Parian","year":"2015","unstructured":"Parian AM, Limnetic BN, Shah ND, Mullin GE. Nutraceutical supplements for inflammatory bowel disease. Nutr Clin Pract. 2015;30(4):551\u20138. https:\/\/doi.org\/10.1177\/0884533615586598.","journal-title":"Nutr Clin Pract"},{"issue":"41","key":"463_CR143","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ctim.2018.09.026","volume":"1","author":"KM Shirazi","year":"2018","unstructured":"Shirazi KM, Nikniaz Z, Shirazi AM, Rohani M. Vitamin A supplementation decreases disease activity index in patients with ulcerative colitis: a randomized controlled clinical trial. Complement Ther Med. 2018;1(41):215\u20139. https:\/\/doi.org\/10.1016\/j.ctim.2018.09.026.","journal-title":"Complement Ther Med"},{"issue":"6","key":"463_CR144","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1248\/bpb.b18-00967","volume":"42","author":"K Kondo","year":"2019","unstructured":"Kondo K, Hiramoto K, Yamate Y, Goto K, Sekijima H, Ooi K. Ameliorative effect of high-dose vitamin C administration on dextran sulfate sodium-induced colitis mouse model. Biol Pharm Bull. 2019;42(6):954\u20139. https:\/\/doi.org\/10.1248\/bpb.b18-00967.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"463_CR145","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12986-021-00576-x","volume":"18","author":"F Qiu","year":"2021","unstructured":"Qiu F, Zhang Z, Yang L, Li R, Ma Y. Combined effect of vitamin C and vitamin D3 on intestinal epithelial barrier by regulating Notch signaling pathway. Nutr Metab. 2021;18(1):49. https:\/\/doi.org\/10.1186\/s12986-021-00576-x.","journal-title":"Nutr Metab"},{"key":"463_CR146","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1155\/2022\/6836942","volume":"20","author":"X Guo","year":"2022","unstructured":"Guo X, Liu C, Huang Y. Efficacy and safety of vitamin d adjuvant therapy for ulcerative colitis: a meta-analysis. Comput Math Methods Med. 2022;20:2022. https:\/\/doi.org\/10.1155\/2022\/6836942.","journal-title":"Comput Math Methods Med"},{"issue":"163","key":"463_CR147","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.freeradbiomed.2020.12.017","volume":"1","author":"KY Liu","year":"2021","unstructured":"Liu KY, Nakatsu CH, Jones-Hall Y, Kozik A, Jiang Q. Vitamin E alpha-and gamma-tocopherol mitigate colitis, protect intestinal barrier function and modulate the gut microbiota in mice. Free Radical Biol Med. 2021;1(163):180\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.12.017.","journal-title":"Free Radical Biol Med"},{"issue":"254","key":"463_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117189","volume":"15","author":"W Niu","year":"2021","unstructured":"Niu W, Chen X, Xu R, Dong H, Yang F, Wang Y, Zhang Z, Ju J. Polysaccharides from natural resources exhibit great potential in the treatment of ulcerative colitis: a review. Carbohyd Polym. 2021;15(254): 117189. https:\/\/doi.org\/10.1016\/j.carbpol.2020.117189.","journal-title":"Carbohyd Polym"},{"issue":"20","key":"463_CR149","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3390\/foods12203800","volume":"12","author":"S Yan","year":"2023","unstructured":"Yan S, Yin L, Dong R. Inhibition of IEC-6 cell proliferation and the mechanism of ulcerative colitis in C57BL\/6 Mice by Dandelion root polysaccharides. Foods. 2023;12(20):3800. https:\/\/doi.org\/10.3390\/foods12203800.","journal-title":"Foods"},{"key":"463_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2020.109777","volume":"138","author":"W Feng","year":"2020","unstructured":"Feng W, Liu J, Tan Y, Ao H, Wang J, Peng C. Polysaccharides from Atractylodes macrocephala Koidz Ameliorate ulcerative colitis via extensive modification of gut microbiota and host metabolism. Food Res Int. 2020;138: 109777. https:\/\/doi.org\/10.1016\/j.foodres.2020.109777.","journal-title":"Food Res Int"},{"issue":"248","key":"463_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112303","volume":"10","author":"JA Batista","year":"2020","unstructured":"Batista JA, de Aguiar Magalh\u00e3es D, Sousa SG, dos Santos FJ, Pereira CM, do Nascimento Lima JV, de Albuquerque IF, Bezerra NL, de Brito TV, da Silva Monteiro CE, Franco AX. Polysaccharides derived from Morinda citrifolia Linn. reduce inflammatory markers during experimental colitis. J Ethnopharmacol. 2020;10(248): 112303. https:\/\/doi.org\/10.1016\/j.jep.2019.112303.","journal-title":"J Ethnopharmacol"},{"key":"463_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2023.102788","volume":"53","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu Y, Luo J, Liu Y, Yu S, Liu J. Rheum tanguticum polysaccharide alleviates DSS-induced ulcerative colitis and regulates intestinal microbiota in mice. Food Biosci. 2023;53: 102788. https:\/\/doi.org\/10.1016\/j.fbio.2023.102788.","journal-title":"Food Biosci"},{"issue":"4","key":"463_CR153","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/jam.15406","volume":"132","author":"YJ Kye","year":"2022","unstructured":"Kye YJ, Lee SY, Kim HR, Lee BH, Park JH, Park MS, Ji GE, Sung MK. Lactobacillus acidophilus PIN7 paraprobiotic supplementation ameliorates DSS-induced colitis through anti-inflammatory and immune regulatory effects. J Appl Microbiol. 2022;132(4):3189\u2013200. https:\/\/doi.org\/10.1111\/jam.15406.","journal-title":"J Appl Microbiol"},{"issue":"8","key":"463_CR154","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1039\/D1FO00017A","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhao Y, Jiang J, Yu L, Tian F, Zhao J, Zhang H, Chen W, Zhai Q. Identification of the key characteristics of Bifidobacterium longum strains for the alleviation of ulcerative colitis. Food Funct. 2021;12(8):3476\u201392. https:\/\/doi.org\/10.1039\/D1FO00017A.","journal-title":"Food Funct"},{"issue":"13","key":"463_CR155","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1039\/D2FO00546H","volume":"13","author":"N Liu","year":"2022","unstructured":"Liu N, Wang H, Yang Z, Zhao K, Li S, He N. The role of functional oligosaccharides as prebiotics in ulcerative colitis. Food Funct. 2022;13(13):6875\u201393. https:\/\/doi.org\/10.1039\/D2FO00546H.","journal-title":"Food Funct"},{"issue":"1","key":"463_CR156","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/foods12010220","volume":"12","author":"A Wu","year":"2023","unstructured":"Wu A, Gao Y, Kan R, Ren P, Xue C, Kong B, Tang Q. Alginate oligosaccharides prevent dextran-sulfate-sodium-induced ulcerative colitis via enhancing intestinal barrier function and modulating gut microbiota. Foods. 2023;12(1):220. https:\/\/doi.org\/10.3390\/foods12010220.","journal-title":"Foods"},{"issue":"180","key":"463_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.114009","volume":"1","author":"W Chen","year":"2023","unstructured":"Chen W, Tan D, Yang Z, Tang J, Bai W, Tian L. Fermentation patterns of prebiotics fructooligosaccharides-SCFA esters inoculated with fecal microbiota from ulcerative colitis patients. Food Chem Toxicol. 2023;1(180): 114009. https:\/\/doi.org\/10.1016\/j.fct.2023.114009.","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"463_CR158","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/nu14102102","volume":"14","author":"J Mota","year":"2022","unstructured":"Mota J, Casimiro S, Fernandes J, Hartmann RM, Schemitt E, Picada J, Costa L, Marroni N, Raymundo A, Lima A, Ferreira RB. Lupin protein concentrate as a novel functional food additive that can reduce colitis-induced inflammation and oxidative stress. Nutrients. 2022;14(10):2102. https:\/\/doi.org\/10.3390\/nu14102102.","journal-title":"Nutrients"},{"issue":"5","key":"463_CR159","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1039\/D1FO02482E","volume":"13","author":"B Zhang","year":"2022","unstructured":"Zhang B, Xu Y, Zhao C, Zhang Y, Lv H, Ji X, Wang J, Pang W, Wang X, Wang S. Protective effects of bioactive peptides in foxtail millet protein hydrolysates against experimental colitis in mice. Food Funct. 2022;13(5):2594\u2013605. https:\/\/doi.org\/10.1039\/D1FO02482E.","journal-title":"Food Funct"},{"issue":"3","key":"463_CR160","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/md19030127","volume":"19","author":"XW Xiang","year":"2021","unstructured":"Xiang XW, Zhou XL, Wang R, Shu CH, Zhou YF, Ying XG, Zheng B. Protective effect of tuna bioactive peptide on dextran sulfate sodium-induced colitis in mice. Mar Drugs. 2021;19(3):127. https:\/\/doi.org\/10.3390\/md19030127.","journal-title":"Mar Drugs"},{"issue":"11","key":"463_CR161","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/nu15112606","volume":"15","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Wang D, Duan H, Zhou S, Guo J, Yan W. The potential of natural oils to improve inflammatory bowel disease. Nutrients. 2023;15(11):2606. https:\/\/doi.org\/10.3390\/nu15112606.","journal-title":"Nutrients"},{"issue":"5","key":"463_CR162","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/nu12051302","volume":"12","author":"A Bartoszek","year":"2020","unstructured":"Bartoszek A, Makaro A, Bartoszek A, Kordek R, Fichna J, Salaga M. Walnut oil alleviates intestinal inflammation and restores intestinal barrier function in mice. Nutrients. 2020;12(5):1302. https:\/\/doi.org\/10.3390\/nu12051302.","journal-title":"Nutrients"},{"issue":"2","key":"463_CR163","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jnutbio.2013.10.005","volume":"25","author":"T Takashima","year":"2014","unstructured":"Takashima T, Sakata Y, Iwakiri R, Shiraishi R, Oda Y, Inoue N, Nakayama A, Toda S, Fujimoto K. Feeding with olive oil attenuates inflammation in dextran sulfate sodium-induced colitis in rat. J Nutr Biochem. 2014;25(2):186\u201392. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.10.005.","journal-title":"J Nutr Biochem"},{"key":"463_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2019.103602","volume":"64","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Ma L, Zhao W, Zhao W, Han X, Niu J, Li R, Zhao C. Flaxseed oil alleviates dextran sulphate sodium-induced ulcerative colitis in rats. J Funct Foods. 2020;64: 103602. https:\/\/doi.org\/10.1016\/j.jff.2019.103602.","journal-title":"J Funct Foods."},{"issue":"7","key":"463_CR165","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1089\/jmf.2018.4323","volume":"22","author":"JS Park","year":"2019","unstructured":"Park JS, Choi J, Hwang SH, Kim JK, Kim EK, Lee SY, Lee BI, Park SH, Cho ML. Cottonseed oil protects against intestinal inflammation in dextran sodium sulfate-induced inflammatory bowel disease. J Med Food. 2019;22(7):672\u20139. https:\/\/doi.org\/10.1089\/jmf.2018.4323.","journal-title":"J Med Food"},{"issue":"11","key":"463_CR166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241337","volume":"15","author":"K Uchiyama","year":"2020","unstructured":"Uchiyama K, Takami S, Suzuki H, Umeki K, Mochizuki S, Kakinoki N, Iwamoto J, Hoshino Y, Omori J, Fujimori S, Yanaka A. Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: an investigator-initiated multicenter double-blind clinical trial. PLoS ONE. 2020;15(11): e0241337. https:\/\/doi.org\/10.1371\/journal.pone.0241337.","journal-title":"PLoS ONE"},{"issue":"11","key":"463_CR167","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/nu10111779","volume":"10","author":"E Papada","year":"2018","unstructured":"Papada E, Forbes A, Amerikanou C, Torovi\u0107 L, Kalogeropoulos N, Tzavara C, Triantafillidis JK, Kaliora AC. Antioxidative efficacy of a Pistacia lentiscus supplement and its effect on the plasma amino acid profile in inflammatory bowel disease: a randomised, double-blind, Placebo-Controlled Trial. Nutrients. 2018;10(11):1779. https:\/\/doi.org\/10.3390\/nu10111779.","journal-title":"Nutrients"},{"issue":"44","key":"463_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2021.101444","volume":"1","author":"A Baghizadeh","year":"2021","unstructured":"Baghizadeh A, Davati A, Heidarloo AJ, Emadi F, Aliasl J. Efficacy of Plantago major seed in management of ulcerative colitis symptoms: a randomized, placebo controlled, clinical trial. Complement Ther Clin Pract. 2021;1(44): 101444. https:\/\/doi.org\/10.1016\/j.ctcp.2021.101444.","journal-title":"Complement Ther Clin Pract"}],"container-title":["Natural Products and Bioprospecting"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-024-00463-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13659-024-00463-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13659-024-00463-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T06:23:46Z","timestamp":1722320626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13659-024-00463-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":168,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["463"],"URL":"https:\/\/doi.org\/10.1007\/s13659-024-00463-x","relation":{},"ISSN":["2192-2195","2192-2209"],"issn-type":[{"value":"2192-2195","type":"print"},{"value":"2192-2209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}